| Arix Bioscience PLC (ARIX)
PDMR Notification & Director Shareholding
10-Nov-2023 / 07:00 GMT/BST
Arix Bioscience plc
("Company") PDMR Notification & Director Shareholding Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them The Company has been notified that Andrew Smith, Non-Executive Director of the Company purchased 25,000 Ordinary shares of 0.001 pence each in the Company (“Shares”) on 9th November 2023 at a price of £1.13 per share. | 1 | Details of the person discharging managerial responsibilities / person closely associated | | a) | Name | Andrew Smith | | 2 | Reason for the notification | | a) | Position/status | Non-Executive Director | | b) | Initial notification /Amendment | Initial Notification | | 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | | a) | Name | Arix Bioscience plc | | b) | LEI | 213800OVT3AHQCXNIX43 | | 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | | a) | Description of the financial instrument, type of instrument | Arix Bioscience plc Ordinary shares of 0.001 pence each | | Identification code | GB00BD045071 | | b) | Nature of the transaction | Share purchase | | c) | Price(s) and volume(s) | | Price(s)£ | Volume(s) | | | | | 1.13 | 25,000 | | | d) | Aggregated information | | | - Aggregated volume | 25,000 | | - Price | £28,174.25 | | e) | Date of the transaction | 9 November 2023 | | f) | Place of the transaction | London Stock Exchange |
For further information please contact:
Kin Company Secretarial Limited, Company Secretary
+44 20 8819 6486
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
|
| | |
| ISIN: | GB00BD045071 |
| Category Code: | DSH |
| TIDM: | ARIX |
| LEI Code: | 213800OVT3AHQCXNIX43 |
| OAM Categories: | 3.1. Additional regulated information required to be disclosed under the laws of a Member State |
| Sequence No.: | 283953 |
| EQS News ID: | 1770099 |
| |
| End of Announcement | EQS News Service |
UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.